Trials / Completed
CompletedNCT01491503
A Drug Interaction Study of Montelukast and Levocetirizine
Open Label, Randomized, 6-sequence Crossover Study to Evaluate the Drug-drug Interaction Between Montelukast Sodium and Levocetirizine Dihydrochloride in Health Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the drug-drug interaction between montelukast sodium and levocetirizine dihydrochloride in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levocetirizine | Levocetirizine dihydrochloride 5mg. PO. Single dose. |
| DRUG | montelukast sodium | Montelukast sodium 10mg. PO. Single dose. |
| DRUG | Montelukast & levocetirizine | Montelukast sodium 10mg \& levocetirizine dihydrochloride 5mg PO. Single dose. |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2011-12-14
- Last updated
- 2013-04-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01491503. Inclusion in this directory is not an endorsement.